✦ LIBER ✦

1064 TARGETING TLR7 AND 9: A NOVEL STRATEGY FOR TREATMENT OF CHOLANGIOCARCINOMA

✍ Scribed by Mohamed, F.E.z.; Davies, N.; Winstaly, A.; Loung, T.; Habtesion, A.; Dahr, D.; Andreola, F.; Minouge, S.; Olde Damink, S.; Mookerjee, R.; Jalan, R.

Book ID: 122629238
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 185 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)61065-X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

294 TLR 9 INHIBITION: A NOVEL TARGET OF

294 TLR 9 INHIBITION: A NOVEL TARGET OF THERAPY FOR PRIMARY LIVER CANCER

✍ F.E.Z. Mohamed; S. Minogue; D. Dhar; N. Shah; N. Davies; A. Habtesion; T.V. Luon 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Targeting protein neddylation: a novel t

Targeting protein neddylation: a novel therapeutic strategy for the treatment of cancer

✍ Wang, Meng; Medeiros, Bruno C; Erba, Harry P; DeAngelo, Daniel J; Giles, Francis 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 459 KB

Novel therapeutic strategies and targets

Novel therapeutic strategies and targets for the treatment of stroke

✍ Murphy, Sean 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB

A novel treatment strategy for type 2 di

A novel treatment strategy for type 2 diabetes: Targeting glucose variability and β-cell failure

✍ Jia Deng; Bochu Wang; Yang Cao; Liancai Zhu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 401 KB

A novel strategy for the treatment of co

A novel strategy for the treatment of cocaine addiction

✍ Stephen L. Dewey; Alexander E. Morgan; Charles R. Ashby Jr.; Bryan Horan; Stepha 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 197 KB 👁 3 views

Cocaine's addictive liability has been linked to its pharmacologic actions on mesotelencephalic dopamine (DA) reinforcement/reward pathways in the central nervous system (CNS). Dopaminergic transmission within these pathways is modulated by gamma-aminobutyric acid (GABA). With this knowledge, we exa

Targeting cytotoxic T-lymphocyte antigen

Targeting cytotoxic T-lymphocyte antigen-4 (CTLA-4) : A novel strategy for the treatment of melanoma and other malignancies

✍ Steven J. O'Day; Omid Hamid; Walter J. Urba 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 511 KB

## Abstract Cancer immunotherapy centers on modulating the host's tumor‐directed immune response. One promising approach involves augmentation of cell‐mediated immunity by interrupting T‐cell pathways responsible for immune down‐regulation or tolerance. The discovery of cytotoxic T‐lymphocyte antig